Zheng Quan Zhi Xing·2025-05-30 10:37Group 1 - The company, Chongqing Laimei Pharmaceutical Co., Ltd., announces that its indirect controlling shareholder, Guangxi Investment Group Co., Ltd., plans to increase capital in Guangxi Investment Group Financial Holding Co., Ltd. by transferring 859,343,587 shares of its direct controlling shareholder, Guangxi Wuzhou Zhongheng Group Co., Ltd., which accounts for 25.94% of Zhongheng Group's total share capital [1][2] - After the transaction, Guangxi Investment Group Financial Holding Co., Ltd. will become the indirect controlling shareholder of the company, while Zhongheng Group will remain the direct controlling shareholder, and the actual controller will still be the Guangxi State-owned Assets Supervision and Administration Commission [1][2] - The transaction is still in the planning stage and requires approval from state-owned assets authorities and other legal procedures [1][3] Group 2 - Prior to the transaction, Zhongheng Group is the direct controlling shareholder, and Guangxi Investment Group is the indirect controlling shareholder, with the actual controller being the Guangxi State-owned Assets Supervision and Administration Commission [2] - The transaction will not affect the company's normal production and operational activities, as it is a change of state-owned equity under the same control [2]